Ivana Spasevska

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Venues

Blood cancer discovery

Blood advances

Molecular cancer therapeutics

Université Claude Bernard Lyon 1 (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Université Claude Bernard Lyon 1

France

BSC

Université Claude Bernard Lyon 1 Nov 01 2014 - Dec 01 2017

France

PHD

École Normale Supérieure Sep 01 2012 - Jul 04 2014

France

MSC :: Biology

Publications

Leo Meriranta, Selma Sorri, Kanutte Huse, Xiaonan Liu, Ivana Spasevska, Sadia Zafar, Iftekhar Chowdury, Olli Dufva, Eerika Sahlberg, Luka Tandaric, Marja-Liisa Karjalainen-Lindsberg, Marko M Hyytiäinen, Markku Varjosalo, June Helen Myklebust, Sirpa Leppa
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma. Blood cancer discovery 5 (5) (2024)
Leo Meriranta, Selma Sorri, Kanutte Huse, Xiaonan Liu, Ivana Spasevska, Sadia Zafar, Iftekhar Chowdury, Olli Dufva, Eerika Sahlberg, Luka Tandaric, Marja-Liisa Karjalainen-Lindsberg, Marko M Hyytiäinen, Markku Varjosalo, June Helen Myklebust, Sirpa Leppa
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-cell Lymphoma. Blood cancer discovery (2024)
Ivana Spasevska, Ankush Sharma, Chloé Beate Steen, Sarah E Josefsson, Yngvild Nuvin Blaker, Arne Kolstad, Even Holth Rustad, Saskia Meyer, Kathrine T Isaksen, Stalin Chellappa, Kushi Kushekhar, Klaus Beiske, Mette S Førsund, Signe Spetalen, Harald Holte, Bjorn Ostenstad, Marianne Brodtkorb, Eva K Kimby, Johanna Olweus, Kjetil Taskén, Aaron M Newman, Susanne Lorenz, Erlend B Smeland, Ash A Alizadeh, Kanutte Huse, June Helen Myklebust
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma. Blood advances (2023)
Ivana Spasevska, Eva Laure Matera, Kamel Chettab, Jade Ville, Marie Potier-Cartereau, Lars Petter Jordheim, Catherine Thieblemont, Denis Sahin, Christiane Neumann, Charles Dumontet
Calcium Channel Blockers Impair the Antitumor Activity of Anti-CD20 Monoclonal Antibodies by Blocking EGR-1 Induction. Molecular cancer therapeutics 19 (11) (2020)

Ivana Spasevska.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ivana Spasevska